Monday, January 10, 2022 4:17:08 PM
New York Yankees and Duke Basketball
Recent MOLN News
- Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action • GlobeNewswire Inc. • 04/29/2024 03:00:00 PM
- Life Science Cares Launches in Switzerland • GlobeNewswire Inc. • 04/19/2024 03:12:41 PM
- Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting • GlobeNewswire Inc. • 04/17/2024 03:12:16 PM
- Molecular Partners Publishes Invitation to Annual General Meeting 2024 • GlobeNewswire Inc. • 03/26/2024 01:26:32 PM
- Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023 • GlobeNewswire Inc. • 03/14/2024 08:00:00 PM
- Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations • GlobeNewswire Inc. • 03/01/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 05:33:05 PM
- Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2024 09:00:06 PM
- Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies • GlobeNewswire Inc. • 01/05/2024 09:00:00 PM
- Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences • GlobeNewswire Inc. • 12/14/2023 06:00:00 AM
- Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting • GlobeNewswire Inc. • 12/10/2023 05:00:00 PM
- Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS) • GlobeNewswire Inc. • 11/14/2023 06:00:00 AM
- Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/02/2023 10:01:04 AM
- Molecular Partners to Present Initial Data from Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at the 65th ASH Annual Meeting and Exposition • GlobeNewswire Inc. • 11/02/2023 06:00:00 AM
- Molecular Partners to Participate in the TD Cowen 7th Annual Fall Oncology Innovation Summit • GlobeNewswire Inc. • 11/01/2023 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/26/2023 08:00:15 PM
- Molecular Partners Interim Management Statement Q3 2023: Continued Validation Seen Across the DARPin Portfolio • GlobeNewswire Inc. • 10/26/2023 08:00:00 PM
- Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Annual Meeting • GlobeNewswire Inc. • 09/13/2023 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/24/2023 08:02:09 PM
- Molecular Partners Reports H1 2023 Corporate Highlights and Financials • GlobeNewswire Inc. • 08/24/2023 08:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/28/2023 12:34:18 PM
- Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023 • GlobeNewswire Inc. • 06/27/2023 05:00:00 AM
- Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit • GlobeNewswire Inc. • 06/19/2023 04:00:00 PM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM